Last reviewed · How we verify

NCT06055322

Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD

Recruiting now NA Last updated 11 May 2025
What this trial tests

NA trial testing Adapted Dialectical Behavior Therapy in Suicide in 100 participants. Currently enrolling.

Timeline
7 January 2025
Primary endpoint
31 August 2026
31 August 2026

Quick facts

Lead sponsorTexas Tech University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date7 January 2025
Primary completion31 August 2026
Estimated completion31 August 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Texas Tech University

Who can join

Adults 50 to 120, any sex, with Suicide or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to adapt, implement, and evaluate a Dialectical Behavior Therapy skills training group intervention for aging adult family caregivers of person with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) to reduce suicidality. By adapting this modality, the investigators will provide a scalable intervention tailored for this high-risk population, maximizing the public health impact and improving suicide prevention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other Texas Tech University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06055322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing